Intersect ENT Expands Footprint to 55 KSF at Menlo Park HQ
- Jan 09, 2015
Intersect ENT has completed a deal for an 18,000-square-foot expansion at its 1555 Adams Drive headquarters in Menlo Park The life sciences company, which is the property’s sole tenant , inked the deal with owner Tarlton Properties, Inc.
The deal increases Intersect ENT’s footprint at 1555 Adans to 50,000 square feet.Intersect ENT’s CEO, Lisa Earnhardt, explained that the building’s size, amenities, location and setting are a good match for the company’s research and development activities.
Intersect ENT focuses on creating therapies for patients with ear, nose, and throat conditions. Currently, The company’s main focus is chronic sinusitis, a common and often debilitating condition. Intersect ENT holds 25 patents in the United States and more than 85 patents and pending applications worldwide.
For more San Francisco area market data, click here.